Discover the JN™ Method™, where toxicological argument and rationale is a strategic pillar.
In many regulatory projects, the term “toxicological argument and rationale” comes up frequently.
Sometimes it’s requested very early on, sometimes urgently, and sometimes simply to resolve a complex situation.
But one essential question is rarely asked:
“What role does toxicological reasoning actually play in the overall regulatory assessment strategy?”
At Toxi Plan, the toxicological case study is not an addendum.
It is a key component of the JN™ (Just Necessary) Method, a strategic approach designed to define the level of regulatory evidence strictly required to demonstrate safety and biocompatibility.
The JN™ Method is based on a simple principle :
Define and deploy the appropriate level of scientific evidence required to demonstrate biocompatibility and regulatory compliance.
In concrete terms, our toxicological assessment strategy is based on five steps, the most crucial of which is the toxicological rationale, as it transforms a technical analysis into a strategic decision regarding the level of regulatory evidence:
1- Analysis of the actual risk
2- Use of existing data
3- Development of the toxicological rationale
4- Definition of the required level of evidence
5- Implementation of tests if necessary
What is a toxicological case study?
A toxicological case study is a structured scientific justification document. Its aim is to demonstrate that the toxicological risk is controlled, consistent with existing data (scientific literature, supplier data, clinical history), the product’s characteristics (materials, substances, conditions of use), realistic exposure scenarios, and the applicable regulatory framework (MDR, ISO 10993, cosmetics regulations, etc.).
The toxicological case study is not about defending a product at all costs. It is about scientifically justifying the level of evidence expected by the authorities or notified bodies.
Why should the toxicological case study precede the decision to conduct tests?
In many medical device biocompatibility projects, tests are considered very early on, either reflexively or proactively.
That’s why, in the JN Method™, we adopt the opposite approach:
The first step is to structure the scientific reasoning.
Then we construct the toxicological case.
Next, we define the required level of regulatory evidence.
Testing is only initiated if the evidence truly warrants it.
The toxicological case then becomes a strategic decision-making tool, not a late-stage fix.
When is the toxicological case strategic?
1- Before a project
Early toxicological analysis helps avoid:
- automatic testing,
- the development of a proportionate strategy,
- the guidance of product design, and the anticipation of MDR and ISO 10993 requirements.
It is at this stage that its power is greatest.
2- During a regulatory file
The toxicological argument is central to:
- CE marking under MDR
- updating a technical file
- responding to a notified body
- providing scientific justification to the authorities
It structures the regulatory scientific justification in a defensible and coherent manner.
3- In a situation of regulatory deadlock
As with any project, obstacles can arise at any point:
- Questions from a notified body.
- Non-compliance.
- Doubts about the necessity of testing.
The toxicological analysis helps clarify the situation, refocus the decision on the actual risk, and objectively define the required level of evidence.
Limitations that should not be ignored
The JN™ Method is not a strategy for avoiding testing. When:
- available data are insufficient
- exposure is significant
- the potential toxicological risk is proven
👉 then testing may be essential.
A toxicological rationale never replaces necessary data. It allows for a rigorous scientific decision to determine when such data is required.
At Toxi Plan, the toxicological rationale is a central component of the JN™ Method.
It allows us to:
- objectively analyze the situation
- structure the scientific justification
- define the appropriate level of evidence required
- align the strategy with regulatory requirements
We don’t aim to do less, nor do we aim to do more. We aim to do exactly what is necessary to demonstrate safety and compliance.
In short, the rationale is a strategic tool, not a mere gimmick. It structures the decision regarding the level of evidence and is more effective proactively than in an emergency. However, it never replaces truly necessary data.
When properly integrated into a comprehensive strategy, it becomes a lever for clarity, consistency, and control.
Disclaimer:
The information provided in this article is for informational and educational purposes only. It does not constitute legal advice nor a personalized regulatory consultation. Despite the care taken in drafting this article and verifying its sources, regulations evolve regularly and may be subject to differing interpretations depending on the specific context of each company, product, or market.
Toxi Plan®, its directors, and its employees shall not be held liable for any use made of the information contained in this article without further analysis tailored to a specific situation. Any regulatory or strategic decision should be based on a specific assessment carried out by a qualified professional, with due regard to the applicable regulations, including any provisions or regulatory practices entering into force after the date of publication.